1 – 5 of 5
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
(
- Contribution to journal › Article
- 2019
-
Mark
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(15). p.7533-7542(
- Contribution to journal › Article
- 2016
-
Mark
Context matters : The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies
(
- Contribution to journal › Article
- 2015
-
Mark
Structure-function analysis of Heterodimer Formation, oligomerization, and receptor binding of the staphylococcus aureus bi-component toxin LukGH
(
- Contribution to journal › Article
- 2012
-
Mark
DETAILED STRUCTURAL INFORMATION OF SPECIFICITY DETERMINING INTERACTIONS IN ENGINEERED CARBOHYDRATE BINDING MODULES
2012) 26th International Carbohydrate Symposium(
- Contribution to conference › Abstract